Does TREPROSTINIL Cause Treatment noncompliance? 755 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 755 reports of Treatment noncompliance have been filed in association with TREPROSTINIL (TYVASO). This represents 0.8% of all adverse event reports for TREPROSTINIL.
755
Reports of Treatment noncompliance with TREPROSTINIL
0.8%
of all TREPROSTINIL reports
53
Deaths
287
Hospitalizations
How Dangerous Is Treatment noncompliance From TREPROSTINIL?
Of the 755 reports, 53 (7.0%) resulted in death, 287 (38.0%) required hospitalization, and 10 (1.3%) were considered life-threatening.
Is Treatment noncompliance Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 755 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Treatment noncompliance?
CLOZAPINE (2,521)
RISPERIDONE (1,986)
APIXABAN (1,749)
ARIPIPRAZOLE (1,583)
NICOTINE (1,382)
PALIPERIDONE (1,218)
ISOTRETINOIN (905)
LENALIDOMIDE (780)
OLANZAPINE (765)
QUETIAPINE (695)
Which TREPROSTINIL Alternatives Have Lower Treatment noncompliance Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE